AI & Agents
GeroQubit
Last updated 2026-07-29 · benchmark measured 2026-08-11 — deterministic & reproducible
De novo drug design platform for longevity and geroscience research.
Is GeroQubit production-ready?
Legit.Show scores GeroQubit 77 out of 100 — the simple average of its 6 measured frames. Legit.Show ran its deterministic 7-Frame production-readiness benchmark on GeroQubit (public-surface assessment), measured from the public surface with no LLM in the scoring path. Its strongest frame is Security; its weakest is Privacy. 6 of the seven frames returned a score; Accessibility was not measurable on this service and is recorded as null — not as zero. Every frame it averages is published with its evidence on the Legit.Show listing.
The 7 Frames
- Performance — 60/100
- Accessibility — not measurable on this service (null — not scored as 0)
- Security — 100/100
- Privacy — 25/100
- Reliability — 100/100
- Standards — 75/100
- Discoverability — 100/100
What we measured
- Security headers present: CSP, HSTS, X-Frame-Options, X-Content-Type-Options, Referrer-Policy.
- Served over HTTPS with a valid certificate.
- Real Lighthouse performance run — 1680 ms to first byte.
- Returns a proper 404 for unknown routes.
- 3 of 3 sampled routes reachable.
- No privacy policy found.
- Sets cookies / loads scripts with no consent prompt.
- Discoverable: structured data, sitemap, OpenGraph image, canonical URL.
Who built it
Dinesh K
Who it's for
Longevity biotechs · Geroscience labs · Drug-hunting teams · Medicinal chemists · Aging research programs
Visit GeroQubit → · Alternatives to GeroQubit → · How this was measured →